The carcinogenic potential of dexrazoxane has not been investigated, however, razoxane, (the racemic mixture of dexrazoxane and levrazoxane), has been reported to be associated with the development of secondary malignancies in mice (lymphoid neoplasms) and rats (uterine carcinomas) after administration for a prolonged period of time.